Researchers developed a novel gene therapy platform that successfully restored muscle function in preclinical models of Duchenne muscular dystrophy by delivering full-length mRNA of the DMD gene via engineered extracellular vesicles. The treatment showed improved muscle strength, endurance, and function without serious side effects.
Researchers at Kyoto University identified DHX29 as a central regulator of codon-dependent gene expression. They found that DHX29 preferentially interacts with ribosomes decoding non-optimal codons and recruits a protein complex to selectively repress mRNAs enriched in these codons.
Researchers develop a new approach for treating inflammatory bowel diseases by delivering locked nucleic acids (LNAs) to the relevant organ using lipid nanoparticles. The study shows improvement in inflammation markers with no side effects, paving the way for potential treatments of rare genetic disorders and other diseases.
A new AI model called RiboNN predicts translation efficiency of mRNA sequences, accelerating the development of mRNA therapeutics. The tool helps predict how much protein cells will produce, minimizing trial-and-error experimentation.
Researchers from Tel Aviv University and the Israel Institute for Biological Research have developed an mRNA-based vaccine against pneumonic plague, a disease caused by Yersinia pestis. The vaccine showed 100% protection in animal models and offers hope for combating other lethal bacteria.
Researchers found that a chemical modification on messenger RNAs triggers disposal while being read by the ribosome, but during cell stress, this process is halted, allowing stress-response proteins to accumulate and help cells recover. The study may have implications for cancer therapies targeting m6A modifications.
Two previously unknown ribosome-arresting peptides (RAPs), PepNL and NanCL, were identified in E. coli, inducing translation arrest through a unique mini-hairpin conformation in the exit tunnel of the ribosome. This discovery provides valuable insights into deciphering the hidden genetic codes within polypeptide sequences.
Bonn researchers have compiled a comprehensive toolbox to characterize IRESes, involving circular RNA reporters and quantitative staining techniques. This enables the direct characterization of IRES-mediated activity in cultured cells and embryo tissue.
Scientists at Nagoya University have developed a new mRNA technology that can produce up to 200 times more protein than traditional methods. This breakthrough enables the creation of healthy proteins to treat illnesses or toxic proteins to kill unwanted cells.
Researchers discovered a novel mechanism of intercellular communication through mRNA transfer between stem cells, allowing for biologically significant effects such as cell fate conversion and pluripotent state maintenance.
Researchers found that olpasiran significantly lowers lipoprotein(a) levels by over 95% and reduces oxidized phospholipids, which promote atherosclerosis. The study also showed no significant effects on inflammatory markers.
Researchers at Ohio State University found that certain tRNA introns suppress gene expression, helping cells respond to oxidative stress. The discovery sheds light on the potential importance of these previously thought-to-be-junk RNA segments in maintaining cellular evolutionary survival.
Researchers developed a new microscopy technique to observe how ribosomes function in cells. They discovered that ribosomes help each other when encountering difficulties, a process they refer to as 'ribosome cooperativity'. This finding provides insights into how proteins are made and offers a tool for better studying mRNA translation.
Researchers at the University of Würzburg have discovered a new degradation process for mRNA that targets proteins involved in cell differentiation. This process, triggered by the m6A modification, is significantly faster and more efficient than previously known mechanisms.
Researchers investigate how perturbed gene expression contributes to neurodegenerative disorders like Alzheimer's. Alternative polyadenylation, a mechanism regulating protein production, is being studied for its potential role in the disease.
Exposure to multiple environmental stressors simultaneously impairs the ability of herring larvae to react at a molecular level, reducing their capacity for acclimatization. This can lead to increased protein damage and cell injury, potentially affecting growth and survival.
A new study in mice shows a unique mRNA delivery method can successfully edit faulty genes in fetal brain cells. The technology has the potential to stop progression of genetic-based neurodevelopmental conditions like Angelman syndrome and Rett syndrome before birth.
A glitch in protein synthesis, known as stop codon readthrough, may affect tumour growth and cancer cell proliferation. The study found that preventing this process can lead to increased degradation of target proteins and a delayed cell cycle, resulting in slower tumour growth.
Researchers developed a cylindrical model called REMM to replicate both inner diameters and chemical properties of ribosome tunnels. The model outperformed a conventional carbon nanotube model in accurately reproducing experimentally observed protein structures.
Acute myeloid leukemia (AML) cells rely on structures called P-bodies to isolate mRNAs that encode proteins suppressing their growth. The discovery of this mechanism may lead to new anti-cancer therapies targeting P-body formation in AML.
A new study published in Nucleic Acid Therapeutics found that siRNA reduces huntingtin mRNA levels in the cytoplasm but not in the nucleus of mouse brains, suggesting a limitation in its effectiveness for treating Huntington's disease. The research highlights the importance of understanding the structure and function of nuclear RNA to ...
LNP-mRNA therapy faces challenges like targeting, quality control, and safety concerns. Researchers are optimizing dosage, addressing CMC requirements, and enhancing targeting efficiency to improve therapeutic outcomes.
A recent study by Johns Hopkins Medicine reveals that the ZAK protein is a critical player in the cell's response to UV radiation damage, determining whether cells live or die. The research, published in Cell, suggests that companies developing drugs targeting ribosomes may find ZAK to be a driver of cell death across cancer types.
Researchers at Arizona State University created a detailed map of the 3'UTR regions of RNA in C. elegans, revealing crucial elements for gene regulation and protein production. The study provides valuable insights into the machinery of gene control, shedding light on fundamental biological processes essential to human health and disease.
A research team from Göttingen University has discovered that antisense RNA (asRNA) plays a crucial role in cell transport, allowing cells to accelerate gene expression and produce proteins quickly in response to environmental stress or harm. This new understanding sheds light on the function of asRNAs and their potential link to disea...
The CCR4-NOT complex plays a crucial role in regulating RNA metabolism and stress response in C. elegans, compromising stress resistance and decreasing lifespan when depleted of subunits. This study highlights an important new role for the CCR4-NOT complex in normal aging and longevity.
Researchers at the University of Alabama at Birmingham have discovered that the protein SRSF1 can bind and unfold complex RNA Guanine-quadruplexes. This finding could provide new avenues for treating illnesses such as cancer, which is often linked to misfunctioning splicing processes.
Researchers at the University of Chicago show that a drug molecule targeting RNA modifications associated with neuroblastoma suppresses tumor growth in mice. High levels of METTL3 expression were linked to significantly lower survival rates in patients, suggesting it drives tumor growth.
Researchers from Osaka University found that influenza-associated brain disorders may be caused by the virus entering the brain and producing proteins. Antivirals blocking protein production are unlikely to be effective, but those targeting transcription and translation may offer hope for treatment.
Researchers used a novel deep proteomics approach to investigate the effects of aging and resistance training on skeletal muscle. The study found that aging predominantly affects non-contractile proteins, while resistance training has minimal effects on protein abundance.
Researchers identified elevated MALAT1 levels in various blood cancers, correlating with adverse outcomes. MALAT1 promotes cancer cell proliferation, migration, invasion, and metastasis through multiple mechanisms.
Researchers have engineered a new mRNA structure by adding multiple “tails” to boost mRNA activity levels and prolong its presence in the body. The multi-tailed mRNAs increased therapeutic protein production in cells and animals, and showed improved efficiency in gene editing when incorporated into a CRISPR system.
Researchers from Tokyo University of Science identify Cpeb4 protein's crucial role in mRNA splicing and osteoclast differentiation, shedding light on bone disease mechanisms. The study's findings may lead to new diagnostic techniques and treatments for conditions like osteoporosis.
Researchers developed an mRNA therapeutic that combats ovarian cancer by producing functional p53 protein, shrinking and killing tumors. The treatment is effective against metastases and has shown promise in preclinical studies.
Researchers aim to decipher function and structure of 1,000 RNA-binding proteins involved in mRNA transport. They hope to gain insights into mRNA stability, relevant to new vaccine development and cancer research.
Researchers have found that antibody sequences contain an unusual number of codons without corresponding tRNAs, which can be bridged by the inosine wobble modification. This modification allows for more efficient production of antibodies, with implications for vaccine efficacy and rationally designed vaccines.
Researchers have successfully used mRNA technology to correct a rare genetic disease in mice, demonstrating its potential therapeutic use. The treatment corrected the lethal consequences of the disease and restored glutathione metabolism.
Researchers found a code directing mRNAs to specific neighborhoods for translation, revealing the cytoplasm's compartmentalization. This discovery sheds light on fundamental cellular biology and holds promise for increasing or altering protein production in mRNA vaccines and therapies.
Plant scientists have discovered a sophisticated RNA defense system that plants use to attack gray mold cells, sending mRNA molecules that disrupt fungal cellular processes. This innovative approach could lead to the development of eco-friendly fungicides with minimal environmental impact and no harm to humans or animals.
A new stem cell treatment using mRNA technology from COVID-19 vaccines has shown promise in regenerating liver tissue, potentially reversing chronic and acute liver diseases. The treatment stimulates the natural repair mechanism of the liver by activating specific receptors on stem cells.
Researchers discovered a novel family of effector proteins called Cami1 that inhibit translation in bacteria attacked by viruses. By cleaving specific mRNAs, Cami1 prevents the production of viral proteins, allowing the bacterium to conserve resources.
Researchers found that cancer cells are more vulnerable to radiotherapy when using the less common 'YC' first-base-cytosine site instead of the usual 'YR' adenine or guanine start sites. This discovery enables further understanding of gene regulation in cancers and potential targets for treatment.
Researchers at Goethe University Frankfurt have identified a specific gene locus, MYNRL15, that is critical to the survival and replication of leukemia cells. Inhibiting this gene has been shown to deactivate genes necessary for AML cell survival, offering a new possibility for fighting leukemia.
Scientists designed an mRNA nanovaccine using machine learning to overcome delivery barriers, promoting strong immune responses and activating the STING pathway to kill tumor cells. The therapeutic strategy demonstrated stronger anti-tumor effects in melanoma and colorectal cancer models.
Researchers developed a new base modification, Z-mRNA, that demonstrates low immunogenicity and reduced cytotoxicity compared to unmodified mRNAs. The modified mRNA can induce a substantial immune response and has potential therapeutic applications beyond COVID-19 vaccines.
Researchers at Weill Cornell Medicine have discovered that a tiny chemical modification on mRNAs, known as m6A, is key to the formation of stress granules during cell stress. Longer mRNAs dominate stress granules because they have high levels of m6A, which triggers their sequestration.
A new molecular mechanism has been identified that helps plants adjust protein levels to fight infection. By unzipping specific RNA structures, plant cells can produce defense proteins. This discovery also has implications for human cells, suggesting a similar mechanism may control protein production in response to pathogens.
Researchers at the University of Alabama at Birmingham have developed a modified messenger RNA that can temporarily induce cardiomyocyte cell division, leading to reduced infarct size and improved heart function. The treatment has shown promise in mouse and pig models without increasing the risk of deadly arrhythmias.
CHOP and Penn Medicine researchers have developed a proof-of-concept model for delivering gene editing tools directly into diseased blood cells within the body. This approach aims to reduce costs and increase access to gene therapies for blood disorders, which currently require chemotherapy and stem cell transplants.
Gang Bao's lab receives a 4-year, $2.6 million grant from the National Institutes of Health to investigate the safety and efficacy of using gene editing treatments like CRISPR-Cas9 to treat sickle cell disease. The team aims to understand the mechanisms behind large gene modifications and their biological consequences.
Researchers have developed a method to produce highly active mRNA vaccines at high purity using a unique cap to easily separate the desired capped mRNA. This 'Purecap' technique extracted up to 100% pure Cap2-type mRNA, which showed improved protein production and lower immunostimulatory activity.
A novel antisense therapy has restored fragile X protein production in human cell samples, revealing aberrant alternative splicing of messenger RNA as a key factor in fragile X syndrome. This finding offers real hope for developing new treatments and improving the lives of individuals affected by the condition.
Researchers identified mRNAs and long non-coding RNAs targeted by stress granule proteins, which accumulate AD-associated gene transcripts in these structures. SGs may play a key role in regulating AD development through the impairment of protein neurohomeostasis.
Researchers found that a mutation in RPL3L, expressed only in heart and skeletal muscle, leads to impaired cardiac contractility by causing ribosomal collisions and protein folding abnormalities. The study aims to develop new treatments for cardiomyopathy and atrial fibrillation.
Scientists are investigating how brain immune cells called microglia change shape in response to hazards using gene transcripts as molecular mediators. The goal is to gain insights into the mechanisms involved and potentially develop new therapies for neurodegenerative diseases.
Researchers from Baidu Research have developed an AI algorithm, LinearDesign, that boosts COVID-19 mRNA vaccine antibody response by 128-fold. The algorithm takes a mere 11 minutes to generate the most stable mRNA sequence encoding Spike protein.
The funding will support the development of next-generation delivery technology for mRNA vaccines and CRISPR-based genome editing. This will enable broader application of messenger RNA therapeutics, including for various diseases and immunological properties of nanoparticles.
A specialized mRNA translation circuit controlled by protein RBPMS determines the competence for heart formation in human embryonic development. The study provides a better understanding of human cardiac development and reveals potential molecular targets for therapeutic interventions.
Researchers have developed a new method for downregulating gene translation in plants using upstream open reading frames (uORFs). The study, published in Nature Biotechnology, demonstrates the potential for precise and incremental regulation of gene expression.
A protein complex formed of HuR and YB1 is crucial for messenger RNA stability during muscle-fiber formation. Further research could help scientists influence protein synthesis and develop novel therapeutics for muscle-related pathologies.